{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:19:31Z","timestamp":1787815171069,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-05200-1","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:04:31Z","timestamp":1786439071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlation between aqueous humour cytokine and imaging biomarker in Central Retinal Vein Occlusion-Macular Edema"],"prefix":"10.1186","volume":"26","author":[{"given":"Jie","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maojuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"5200_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","volume":"63","author":"A Daruich","year":"2018","unstructured":"Daruich A, Matet A, Moulin A, Kowalczuk L, Nicolas M, Sellam A, et al. Mechanisms of macular edema: beyond the surface. Prog Retin Eye Res. 2018;63:20\u201368. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.10.006. Epub 2017 Nov 7. PMID: 29126927.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"5200_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/112067211002000222","volume":"20","author":"H Noma","year":"2010","unstructured":"Noma H, Funatsu H, Mimura T, Harino S, Hori S. Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion. Eur J Ophthalmol. 2010;20(2):402\u201309. https:\/\/doi.org\/10.1177\/112067211002000222.","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"5200_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1755-3768.2009.01524.x","volume":"88","author":"H Noma","year":"2010","unstructured":"Noma H, Funatsu H, Mimura T, Harino S, Sone T, Hori S. Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular oedema and central retinal vein occlusion. Acta Ophthalmol. 2010;88(6):646\u201351. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01524.x.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"5200_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.22608\/APO.2017442","volume":"7","author":"M Ip","year":"2018","unstructured":"Ip M, Hendrick A. Retinal vein occlusion review. Asia Pac J Ophthalmol (Phila). 2018;7(1):40\u201345. https:\/\/doi.org\/10.22608\/APO.2017442.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"11","key":"5200_CR5","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1097\/IAE.0000000000000859","volume":"35","author":"A Couturier","year":"2015","unstructured":"Couturier A, Man\u00e9 V, Bonnin S, Erginay A, Massin P, Gaudric A, et al. Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography. Retina. 2015;35(11):2384\u201391. https:\/\/doi.org\/10.1097\/IAE.0000000000000859.","journal-title":"Retina"},{"key":"5200_CR6","doi-asserted-by":"publisher","first-page":"861757","DOI":"10.3389\/fendo.2022.861757","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Cao X, Zhao M, Bao Y. The changes of irisin and inflammatory cytokines in the age-related macular degeneration and retinal vein occlusion. Front Endocrinol (Lausanne). 2022;13:861757. https:\/\/doi.org\/10.3389\/fendo.2022.861757.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5200_CR7","doi-asserted-by":"publisher","first-page":"1186025","DOI":"10.3389\/fnins.2023.1186025","volume":"17","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Qi J, Liu H, Liang S, Guo T, Chen J, et al. Increased intraocular inflammation in retinal vein occlusion is independent of circulating immune mediators and is involved in retinal oedema. Front Neurosci. 2023;17:1186025. https:\/\/doi.org\/10.3389\/fnins.2023.1186025.","journal-title":"Front Neurosci"},{"issue":"1","key":"5200_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/2474126419880391","volume":"4","author":"SA Minaker","year":"2019","unstructured":"Minaker SA, Mason RH, Bamakrid M, Lee Y, Muni RH. Changes in aqueous and vitreous inflammatory cytokine levels in retinal vein occlusion: a systematic review and meta-analysis. J Vitreoretin Dis. 2019;4(1):36\u201364. https:\/\/doi.org\/10.1177\/2474126419880391. PMID: 37009560; PMCID: PMC9976078.","journal-title":"J Vitreoretin Dis"},{"issue":"1","key":"5200_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1089\/jop.2020.0035","volume":"37","author":"W Cui","year":"2021","unstructured":"Cui W, Sun XY, Sun LP, Li J, Liu ZL, Zhang H. Comparison of the effect of intravitreal conbercept and ranibizumab on aqueous humor cytokines in central retinal vein occlusion-related macular edema. J Ocul Pharmacol Ther. 2021;37(1):52\u201359. https:\/\/doi.org\/10.1089\/jop.2020.0035. Epub 2020 Nov 19.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"5200_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11892-019-1188-4","volume":"19","author":"EJ Kim","year":"2019","unstructured":"Kim EJ, Lin WV, Rodriguez SM, Chen A, Loya A, Weng CY. Treatment of diabetic macular edema. Curr Diab Rep. 2019;19(9):68. https:\/\/doi.org\/10.1007\/s11892-019-1188-4.","journal-title":"Curr Diab Rep"},{"key":"5200_CR11","doi-asserted-by":"publisher","first-page":"104114","DOI":"10.1016\/j.compbiomed.2020.104114","volume":"129","author":"RA Karlsson","year":"2021","unstructured":"Karlsson RA, Jonsson BA, Hardarson SH, Olafsdottir OB, Halldorsson GH, Stefansson E. Automatic fundus image quality assessment on a continuous scale. Comput Biol Med. 2021;129:104114. https:\/\/doi.org\/10.1016\/j.compbiomed.2020.104114.","journal-title":"Comput Biol Med"},{"issue":"1","key":"5200_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/bjo-2022-321963","volume":"108","author":"M K\u00f6nig","year":"2023","unstructured":"K\u00f6nig M, Seeb\u00f6ck P, Gerendas BS, Mylonas G, Winklhofer R, Dimakopoulou I, et al. Quality assessment of colour fundus and fluorescein angiography images using deep learning. Br J Ophthalmol. 2023;108(1):98\u2013104. https:\/\/doi.org\/10.1136\/bjo-2022-321963.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"5200_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/CH-221634","volume":"83","author":"AG Koutsiaris","year":"2023","unstructured":"Koutsiaris AG, Batis V, Liakopoulou G, Tachmitzi SV, Detorakis ET, Tsironi EE. Optical coherence tomography angiography (OCTA) of the eye: a review on basic principles, advantages, disadvantages and device specifications. Clin Hemorheol Microcirc. 2023;83(3):247\u201371. https:\/\/doi.org\/10.3233\/CH-221634.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"3","key":"5200_CR14","doi-asserted-by":"publisher","first-page":"030502","DOI":"10.11613\/BM.2020.030502","volume":"30","author":"S Ka\u0161telan","year":"2020","unstructured":"Ka\u0161telan S, Ore\u0161kovi\u0107 I, Bi\u0161\u0107an F, Ka\u0161telan H, Gverovi\u0107 Antunica A. Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochem Med (Zagreb). 2020;30(3):030502. https:\/\/doi.org\/10.11613\/BM.2020.030502.","journal-title":"Biochem Med (Zagreb)"},{"key":"5200_CR15","doi-asserted-by":"publisher","first-page":"668107","DOI":"10.3389\/fmed.2021.668107","volume":"8","author":"CT Lai","year":"2021","unstructured":"Lai CT, Hsieh YT, Lin CJ, Wang JK, Lin CY, Hsia NY, et al. Age, initial central retinal thickness, and OCT biomarkers have an influence on the outcome of diabetic macular edema treated with ranibizumab\u2013 tri-center 12-month treat-and-extend study. Front Med (Lausanne). 2021;8:668107. https:\/\/doi.org\/10.3389\/fmed.2021.668107.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"5200_CR16","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/s41433-024-03058-5","volume":"38","author":"D Kazantzis","year":"2024","unstructured":"Kazantzis D, Holmes C, Wijesingha N, Sivaprasad S. Changes in foveal avascular zone parameters in individuals with prediabetes compared to normoglycemic controls: a systematic review and meta-analysis. Eye (Lond). 2024;38(10):1855\u201360. https:\/\/doi.org\/10.1038\/s41433-024-03058-5.","journal-title":"Eye (Lond)"},{"key":"5200_CR17","doi-asserted-by":"publisher","first-page":"104743","DOI":"10.1016\/j.mvr.2024.104743","volume":"157","author":"B Pereira","year":"2025","unstructured":"Pereira B, Faria R, Domingues C, Barros A, Varandas T, Henriques J, et al. Foveal avascular zone area measurement in diabetic patients: superficial, deep or combined retinal vascular complex? Microvasc Res. 2025;157:104743. https:\/\/doi.org\/10.1016\/j.mvr.2024.104743.","journal-title":"Microvasc Res"},{"issue":"7","key":"5200_CR18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.oret.2024.12.015","volume":"9","author":"BV Duffy","year":"2025","unstructured":"Duffy BV, Castellanos-Canales D, Decker NL, Lee HJ-A, Yamaguchi TC, Pearce E, et al. Foveal avascular zone enlargement correlates with visual acuity decline in patients with diabetic retinopathy. Ophthalmol Retina. 2025;9(7):667\u201376. https:\/\/doi.org\/10.1016\/j.oret.2024.12.015.","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"5200_CR19","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.4103\/ijo.IJO_74_22","volume":"70","author":"D Kumawat","year":"2022","unstructured":"Kumawat D, Chawla R, Shah P, Sharma A, Sachan A, Pandey V. Automated and ImageJ thresholding algorithm-based analysis of macular vessel density in diabetic patients. Indian J Ophthalmol. 2022;70(6):2050\u201356. https:\/\/doi.org\/10.4103\/ijo.IJO_74_22.","journal-title":"Indian J Ophthalmol"},{"issue":"11","key":"5200_CR20","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/j.ophtha.2016.07.010","volume":"123","author":"J Lee","year":"2016","unstructured":"Lee J, Moon BG, Cho AR, Yoon YH. Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response. Ophthalmology. 2016;123(11):2368\u201375. https:\/\/doi.org\/10.1016\/j.ophtha.2016.07.010.","journal-title":"Ophthalmology"},{"issue":"9","key":"5200_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.oret.2022.03.020","volume":"6","author":"H Huang","year":"2022","unstructured":"Huang H, Jansonius NM, Chen H, Los LI. Hyperreflective dots on OCT as a predictor of treatment outcome in diabetic macular edema: a systematic review. Ophthalmol Retina. 2022;6(9):814\u201327. https:\/\/doi.org\/10.1016\/j.oret.2022.03.020.","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"5200_CR22","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.oret.2023.07.016","volume":"7","author":"A Jhaveri","year":"2023","unstructured":"Jhaveri A, Martins Melo I, Pecaku A, Zajner C, Naidu S, Batawi H, et al. Outer retinal hyperreflective dots: a potential imaging biomarker in rhegmatogenous retinal detachment. Ophthalmol Retina. 2023;7(12):1087\u201396. https:\/\/doi.org\/10.1016\/j.oret.2023.07.016.","journal-title":"Ophthalmol Retina"},{"issue":"22","key":"5200_CR23","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.3390\/jcm11226646","volume":"11","author":"MEW Torm","year":"2022","unstructured":"Torm MEW, Sander B, Hornum M, Krohn P, Birn H, Larsen M. Characterization of hyperreflective dots by structural and angiographic optical coherence tomography in patients with diabetic retinopathy and healthy subjects. J Clin Med. 2022;11(22):6646. https:\/\/doi.org\/10.3390\/jcm11226646.","journal-title":"J Clin Med"},{"key":"5200_CR24","doi-asserted-by":"publisher","first-page":"9810270","DOI":"10.1155\/2016\/9810270","volume":"2016","author":"BG Moon","year":"2016","unstructured":"Moon BG, Lee JY, Yu HG, Song JH, Park YH, Kim HW, et al. Efficacy and safety of a dexamethasone implant in patients with diabetic macular edema at tertiary centers in Korea. J Ophthalmol. 2016;2016:9810270. https:\/\/doi.org\/10.1155\/2016\/9810270. Epub 2016 May 17.","journal-title":"J Ophthalmol"},{"key":"5200_CR25","doi-asserted-by":"publisher","first-page":"9402198","DOI":"10.1155\/2017\/9402198","volume":"2017","author":"H Wu","year":"2017","unstructured":"Wu H, Hwang DK, Song X, Tao Y. Association between aqueous cytokines and diabetic retinopathy stage. J Ophthalmol. 2017;2017:9402198. https:\/\/doi.org\/10.1155\/2017\/9402198.","journal-title":"J Ophthalmol"},{"issue":"7","key":"5200_CR26","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.3390\/ijms22073427","volume":"22","author":"H Noma","year":"2021","unstructured":"Noma H, Yasuda K, Shimura M. Involvement of cytokines in the pathogenesis of diabetic macular edema. Int J Mol Sci. 2021;22(7):3427. https:\/\/doi.org\/10.3390\/ijms22073427.","journal-title":"Int J Mol Sci"},{"key":"5200_CR27","doi-asserted-by":"publisher","first-page":"8546423","DOI":"10.1155\/2018\/8546423","volume":"2018","author":"S Feng","year":"2018","unstructured":"Feng S, Yu H, Yu Y, Geng Y, Li D, Yang C, et al. Levels of inflammatory cytokines IL-1\u03b2, IL-6, IL-8, IL-17A, and TNF-\u03b1 in aqueous humour of patients with diabetic retinopathy. J Diabetes Res. 2018;2018:8546423. https:\/\/doi.org\/10.1155\/2018\/8546423. PMID: 29850610; PMCID: PMC5904804.","journal-title":"J Diabetes Res"},{"key":"5200_CR28","doi-asserted-by":"publisher","first-page":"6928524","DOI":"10.1155\/2019\/6928524","volume":"2019","author":"J Wu","year":"2019","unstructured":"Wu J, Zhong Y, Yue S, Yang K, Zhang G, Chen L, et al. Aqueous humor mediator and cytokine aberrations in diabetic retinopathy and diabetic macular edema: a systematic review and meta-analysis. Dis Markers. 2019;2019:6928524. https:\/\/doi.org\/10.1155\/2019\/6928524.","journal-title":"Dis Markers"},{"issue":"7","key":"5200_CR29","first-page":"1097","volume":"39","author":"A Yoshida","year":"1998","unstructured":"Yoshida A, Yoshida S, Khalil AK, Ishibashi T, Inomata H. Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization. Invest Ophthalmol Vis Sci. 1998;39(7):1097\u2013106.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"5200_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/iovs.61.2.26","volume":"61","author":"F Wu","year":"2020","unstructured":"Wu F, Phone A, Lamy R, Ma D, Laotaweerungsawat S, Chen Y, et al. Correlation of aqueous, vitreous, and plasma cytokine levels in patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2020;61(2):26. https:\/\/doi.org\/10.1167\/iovs.61.2.26.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"5200_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/gb-2005-6-2-209","volume":"6","author":"DI Holmes","year":"2005","unstructured":"Holmes DI, Zachary I. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005;6(2):209. https:\/\/doi.org\/10.1186\/gb-2005-6-2-209.","journal-title":"Genome Biol"},{"issue":"3","key":"5200_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11095-019-2569-8","volume":"36","author":"M Tamhane","year":"2019","unstructured":"Tamhane M, Cabrera-Ghayouri S, Abelian G, Viswanath V. Review of biomarkers in ocular matrices: challenges and opportunities. Pharm Res. 2019;36(3):40. https:\/\/doi.org\/10.1007\/s11095-019-2569-8.","journal-title":"Pharm Res"},{"issue":"1","key":"5200_CR33","doi-asserted-by":"publisher","first-page":"108380","DOI":"10.1016\/j.jdiacomp.2022.108380","volume":"37","author":"Y Xu","year":"2023","unstructured":"Xu Y, Hou H, Zhao L. The role of VCAM-1 in diabetic retinopathy: a systematic review and meta-analysis. J Diabetes Complications. 2023;37(1):108380. https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108380.","journal-title":"J Diabetes Complications"},{"key":"5200_CR34","doi-asserted-by":"publisher","unstructured":"Nguyen QD, De Falco S, Behar-Cohen F, Lam WC, Li X, Reichhart N, et al. Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases. Acta Ophthalmol. 2018;96(1):e1\u20139. https:\/\/doi.org\/10.1111\/aos.13325.","DOI":"10.1111\/aos.13325"},{"issue":"12","key":"5200_CR35","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3109\/02713683.2010.510257","volume":"35","author":"IK Oh","year":"2010","unstructured":"Oh IK, Kim SW, Oh J, Lee TS, Huh K. Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr Eye Res. 2010;35(12):1116\u201327. https:\/\/doi.org\/10.3109\/02713683.2010.510257.","journal-title":"Curr Eye Res"},{"issue":"4","key":"5200_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2174\/1566524017666171106111440","volume":"17","author":"Y Yu","year":"2017","unstructured":"Yu Y, Zhang J, Zhu R, Zhao R, Chen J, Jin J, et al. The profile of angiogenic factors in vitreous humor of the patients with proliferative diabetic retinopathy. Curr Mol Med. 2017;17(4):280\u201386. https:\/\/doi.org\/10.2174\/1566524017666171106111440.","journal-title":"Curr Mol Med"},{"issue":"10","key":"5200_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1167\/iovs.64.10.8","volume":"64","author":"D Lai","year":"2023","unstructured":"Lai D, Wu Y, Shao C, Qiu Q. The role of m\u00fcller cells in diabetic macular edema. Invest Ophthalmol Vis Sci. 2023;64(10):8. https:\/\/doi.org\/10.1167\/iovs.64.10.8.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"5200_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","volume":"15","author":"N Papadopoulos","year":"2012","unstructured":"Papadopoulos N, Martin J, Ruan Q, Rafique A, Rosconi MP, Shi E, et al. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF trap, ranibizumab and bevacizumab. Angiogenesis. 2012;15(2):171\u201385. https:\/\/doi.org\/10.1007\/s10456-011-9249-6.","journal-title":"Angiogenesis"},{"issue":"6","key":"5200_CR39","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2023.12.026","volume":"131","author":"TY Wong","year":"2024","unstructured":"Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, et al. Faricimab treat-and-extend for diabetic macular edema: two-year results from the randomized phase 3 YOSEMITE and RHINE trials. Ophthalmology. 2024;131(6):708\u201323. https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.026. Epub 2023 Dec 28.","journal-title":"Ophthalmology"},{"issue":"1","key":"5200_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","volume":"127","author":"PU Dugel","year":"2020","unstructured":"Dugel PU, Koh A, Ogura Y, Jaffe GJ, Schmidt-Erfurth U, Brown DM, et al. HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of Brolucizumab for neovascular age-related macular degeneration. Ophthalmology. 2020;127(1):72\u201384. https:\/\/doi.org\/10.1016\/j.ophtha.2019.04.017.","journal-title":"Ophthalmology"},{"issue":"5","key":"5200_CR41","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jcjo.2018.12.005","volume":"54","author":"S Teja","year":"2019","unstructured":"Teja S, Sawatzky L, Wiens T, Maberley D, Ma P. Ozurdex for refractory macular edema secondary to diabetes, vein occlusion, uveitis and pseudophakia. Can J Ophthalmol. 2019;54(5):540\u201347. https:\/\/doi.org\/10.1016\/j.jcjo.2018.12.005.","journal-title":"Can J Ophthalmol"},{"issue":"17","key":"5200_CR42","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3390\/diagnostics14171983","volume":"14","author":"MR Munk","year":"2024","unstructured":"Munk MR, Ceklic L, Stillenmunkes R, Chaudhary V, Waheed N, Chhablani J, et al. Integrated assessment of OCT, multimodal imaging, and cytokine markers for predicting treatment responses in retinal vein occlusion associated macular edema: a comparative review of anti-VEGF and steroid therapies. Diagnostics (Basel). 2024;14(17):1983. https:\/\/doi.org\/10.3390\/diagnostics14171983.","journal-title":"Diagnostics (Basel)"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-05200-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:53:28Z","timestamp":1787813608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-05200-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5200"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-05200-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9449389\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was reviewed by Linyi People\u2019s Hospital. All of the participants signed informed consent forms.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"525"}}